{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:27:30Z","timestamp":1792625250322,"version":"4.5.0"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2019,8,15]]},"abstract":"<jats:p>The purpose of this systematic review is to improve outcomes for the care of surgical site infections by presenting the current best evidence on important diagnostic and care issues. The findings led to ten recommendations and five consensus statements that address diagnosis and treatment of orthopaedic surgical site infections. There is strong evidence to supports anemia, obesity, HIV\/AIDS, depression, dementia, immunosuppressive medications, duration of hospital stay, history of alcohol abuse, and history of congestive heart failure as factors that increased the risk of infection, some of which are modifiable before surgical intervention. Diagnostically, synovial fluid and tissue cultures were found to be strong \u201crule-in\u201d tests for the diagnosis of infection, but negative synovial fluid and tissue cultures do not reliably exclude infection. C-reactive protein was found to be a strong rule-in and rule-out marker for patients with suspected surgical site infections. Therapeutically, only for patients with retained implants, antimicrobial protocols of 8 weeks of duration were found to be associated with outcomes that are not inferior to outcomes from protocols of 3- to 6-month duration. Also only for patients with retained implants, rifampin, used as a second antimicrobial, increases the probability of treatment success for staphylococcal infections. The surgical site infection work group identified a lack of high-level outcomes data, highlighting the need for high-quality clinical trials in the treatment of surgical site infections.<\/jats:p>","DOI":"10.5435\/jaaos-d-18-00653","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T02:36:58Z","timestamp":1546223818000},"page":"e717-e720","source":"Crossref","is-referenced-by-count":27,"title":["AAOS Systematic Literature Review: Summary on the Management of Surgical Site Infections"],"prefix":"10.5435","volume":"27","author":[{"given":"Alexander C.","family":"McLaren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas W.","family":"Lundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-20230714","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Making"},{"key":"R7-20230714","first-page":"131","article-title":"Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities","volume":"29","author":"Angst","year":"2002","journal-title":"J Rheumatol"},{"key":"R8-20230714","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0","article-title":"Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities","volume":"45","author":"Angst","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R9-20230714","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/bmj.316.7132.690","article-title":"Interpreting treatment effects in randomized trials","volume":"316","author":"Guyatt","year":"1998","journal-title":"BMJ"},{"key":"R10-20230714","first-page":"2025","article-title":"Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: Methodological issues","volume":"32","author":"Tubach","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124635-201908150-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:48:46Z","timestamp":1787669326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124635-201908150-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":5,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-18-00653","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,15]]}}}